Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 14,045 | 14,430 | 11,145 | 11,396 | 5,661 |
| Gross Profit | 14,045 | 14,430 | 11,145 | 11,396 | 5,661 |
| Operating Expenses | 7,078 | 6,523 | 6,025 | 6,204 | 7,694 |
| Operating Income | 6,967 | 7,907 | 5,121 | 5,192 | -2,033 |
| Other Income | 66 | 64 | 35 | 72 | 526 |
| Pre-tax Income | 7,033 | 7,971 | 5,155 | 5,263 | -1,507 |
| Income Tax | 2,387 | 2,685 | 2,174 | -1,338 | 1 |
| Net Income Continuous | 4,646 | 5,286 | 2,981 | 6,602 | -1,509 |
| Net Income | $4,646 | $5,286 | $2,981 | $6,602 | $-1,509 |
| EPS Basic Total Ops | 0.72 | 0.83 | 0.47 | 1.04 | -0.24 |
| EPS Basic Continuous Ops | 0.72 | 0.83 | 0.47 | 1.04 | -0.24 |
| EPS Diluted Total Ops | 0.66 | 0.76 | 0.43 | 0.95 | -0.24 |
| EPS Diluted Continuous Ops | 0.66 | 0.76 | 0.43 | 0.95 | -0.24 |
| EPS Diluted Before Non-Recurring Items | 0.66 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $7,214 | $7,971 | $5,031 | $5,243 | $-2,014 |